tiprankstipranks
Advertisement
Advertisement

AU:NSB Stock Latest News

NeuroScientific Extends Insider Escrow as Major Share Block Set for Release
Company AnnouncementsNeuroScientific Extends Insider Escrow as Major Share Block Set for Release
11d ago
NSB
NeuroScientific Director Converts Performance Shares After SAS Milestone
PremiumCompany Announcements
NeuroScientific Director Converts Performance Shares After SAS Milestone
27d ago
NSB
NeuroScientific Issues New ASX Securities Under Disclosure Exemption
PremiumCompany Announcements
NeuroScientific Issues New ASX Securities Under Disclosure Exemption
28d ago
NSB
Neuroscientific Biopharmaceuticals Seeks ASX Quotation for 57 Million New Shares
PremiumCompany Announcements
Neuroscientific Biopharmaceuticals Seeks ASX Quotation for 57 Million New Shares
28d ago
NSB
NeuroScientific Biopharmaceuticals outlines stem cell strategy for severe Crohn’s disease
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals outlines stem cell strategy for severe Crohn’s disease
1M ago
NSB
NeuroScientific Seeks Trading Halt Ahead of Material Program Results
PremiumCompany AnnouncementsNeuroScientific Seeks Trading Halt Ahead of Material Program Results
1M ago
NSB
NeuroScientific advances StemSmart cell therapy with strong early Crohn’s data and scale-up plans
Premium
Company Announcements
NeuroScientific advances StemSmart cell therapy with strong early Crohn’s data and scale-up plans
2M ago
NSB
NeuroScientific scales up StemSmart manufacturing with Q-Gen for Phase 2 trials
Premium
Company Announcements
NeuroScientific scales up StemSmart manufacturing with Q-Gen for Phase 2 trials
3M ago
NSB
NeuroScientific Revenue Surges but Half-Year Loss Deepens and Asset Base Shrinks
PremiumCompany Announcements
NeuroScientific Revenue Surges but Half-Year Loss Deepens and Asset Base Shrinks
4M ago
NSB
NeuroScientific Advances StemSmart™ Program as Crohn’s Trial Prep Gathers Pace
PremiumCompany Announcements
NeuroScientific Advances StemSmart™ Program as Crohn’s Trial Prep Gathers Pace
5M ago
NSB
NeuroScientific’s StemSmart Therapy Delivers Strong Results in Fistulising Crohn’s Patients
PremiumCompany Announcements
NeuroScientific’s StemSmart Therapy Delivers Strong Results in Fistulising Crohn’s Patients
6M ago
NSB
NeuroScientific Biopharmaceuticals Advances Therapeutics for Crohn’s Disease and Neuroprotection
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Advances Therapeutics for Crohn’s Disease and Neuroprotection
8M ago
NSB
NeuroScientific Biopharmaceuticals to Host Investor Webinar on Strategic Advances
PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals to Host Investor Webinar on Strategic Advances
8M ago
NSB
NeuroScientific Advances StemSmart™ Therapy for Crohn’s Disease
Premium
Company Announcements
NeuroScientific Advances StemSmart™ Therapy for Crohn’s Disease
8M ago
NSB
NeuroScientific Biopharmaceuticals Establishes Advisory Board to Drive Innovation
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Establishes Advisory Board to Drive Innovation
8M ago
NSB
NeuroScientific Biopharmaceuticals Advances StemSmart™ for Crohn’s Disease with Strategic Appointments and Partnerships
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Advances StemSmart™ for Crohn’s Disease with Strategic Appointments and Partnerships
8M ago
NSB
Neuroscientific Biopharmaceuticals Expands Manufacturing and Proves Clinical Efficacy
PremiumCompany Announcements
Neuroscientific Biopharmaceuticals Expands Manufacturing and Proves Clinical Efficacy
8M ago
NSB
NeuroScientific’s StemSmart™ Gains TGA Approval for Crohn’s Disease Treatment
PremiumCompany Announcements
NeuroScientific’s StemSmart™ Gains TGA Approval for Crohn’s Disease Treatment
9M ago
NSB
NeuroScientific Biopharmaceuticals Announces Annual General Meeting Details
PremiumCompany Announcements
NeuroScientific Biopharmaceuticals Announces Annual General Meeting Details
9M ago
NSB
NeuroScientific Biopharmaceuticals Announces Annual General Meeting
PremiumCompany AnnouncementsNeuroScientific Biopharmaceuticals Announces Annual General Meeting
9M ago
NSB
Neuroscientific Biopharmaceuticals Announces Change in Substantial Holding
Premium
Company Announcements
Neuroscientific Biopharmaceuticals Announces Change in Substantial Holding
9M ago
NSB
NeuroScientific Biopharmaceuticals Announces AGM and Director Nomination Deadline
Premium
Company Announcements
NeuroScientific Biopharmaceuticals Announces AGM and Director Nomination Deadline
10M ago
NSB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >